ProPhase Labs (PRPH) Reports Q1 Data, 60% Upswing in Net Sales, Expanded and Improved Product Portfolio
ProPhase Labs, the remarkable little medical science company that is currently pursuing a variety of natural health targets and is widely known as the producer of the clinically-proven Cold-EEZE® (based on a proprietary cold remedy formula of zinc gluconate glycine) family of lozenges for the common cold, recently presented a report of the Company’s Q1 2011 results. Chief among the data is a 60% increase in net sales (three-month period ended Mar. 31, 2011) over the same period the previous year, as the Company raked in some $3.2M led by strong uptake of the Cold-EEZE line by retailers. Chairman and…